Cleared Traditional

K081774 - SOLX 790 TITANIUM SAPPHIRE LASER

K081774 is an FDA 510(k) clearance for SOLX 790 TITANIUM SAPPHIRE LASER, manufactured by Solx, Inc.. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 81-day FDA review.

K081774 · Solx, Inc. · Ophthalmic device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2008
Decision
81d
Days
Class 2
Risk

K081774 is an FDA 510(k) clearance for the SOLX 790 TITANIUM SAPPHIRE LASER. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Solx, Inc. (Waltham, US). The FDA issued a Cleared decision on September 12, 2008 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K081774

510(k) Number K081774 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2008
Decision Date September 12, 2008
Days to Decision 81 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 110d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 175
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K081774.
LIGHTLAS SELECTOR
K090774 · Lightmed Corp. · Aug 2009
SUPRA 577.Y LASER
K091581 · Quantel Medical · Jun 2009
SUPRA TWIN OPHTHALMIC LASER PHOTOCOAGULATOR
K081946 · Quantel Medical · Mar 2009
INTEGRE PRO, MODEL L2RY
K081565 · Ellex Medical Pty, Ltd. · Jul 2008
INTEGRE, MODEL LP581
K080423 · Ellex Medical Pty, Ltd. · Mar 2008
MERILAS 532A
K072823 · Meridian AG · Dec 2007
K081774 · SOLX 790 TITANIUM SAPPHIRE LASER
Download PDF FDA Summary Solx, Inc.